U.S. Chemicals Stock News

NasdaqGM:LRMR
NasdaqGM:LRMRBiotechs

Do Positive Friedreich's Ataxia Study Results Shift Larimar Therapeutics’ (LRMR) Long-Term Value Proposition?

Larimar Therapeutics recently announced positive data from its long-term open-label study evaluating daily subcutaneous injections of nomlabofusp in patients with Friedreich's Ataxia, alongside an update on its development program. This milestone highlights progress in advancing novel treatments for a rare neurological disease, capturing interest among rare disease and biotech stakeholders. We’ll explore how the encouraging clinical results for nomlabofusp are influencing Larimar...
NYSE:BKKT
NYSE:BKKTCapital Markets

Bakkt Holdings (BKKT): Evaluating the Valuation After Strategic Shift to Crypto Infrastructure and Board Reshuffle

Bakkt Holdings (BKKT) shares have soared after the company sharpened its focus on crypto custody, stablecoin payments, and treasury management. This follows the sale of its loyalty rewards business and recent board changes. See our latest analysis for Bakkt Holdings. Bakkt’s sharpened focus has breathed new life into its stock, with a notable short-term rally fueled by the shift toward digital assets and a well-received board appointment. While the 1-year total shareholder return sits at...
NasdaqGM:RZLV
NasdaqGM:RZLVSoftware

Rezolve AI (RZLV): Losses Worsen by 38.9% Annually Despite Strong Growth Forecasts Challenging Bull Narratives

Rezolve AI (RZLV) continues to operate at a loss, with net losses accelerating by 38.9% annually over the past five years. Despite negative equity, signaled by a deeply negative Price-To-Book Ratio of -127.6x compared to both peer and industry averages, the company’s earnings are forecast to surge 117.9% per year while revenue is expected to climb 95% annually. These projections are both well ahead of market norms. Shares currently trade at $6.28, notably below an estimated fair value of...
NasdaqGS:HST
NasdaqGS:HSTHotel and Resort REITs

Is There Value Left in Host Hotels After Strong Q1 Earnings and Raised Guidance for 2025?

If you are navigating the world of real estate investment trusts, chances are you are considering what to do with your Host Hotels & Resorts shares right now. You are not alone—investors across the board have been debating whether this stock is a hidden gem or one that is already reflecting its full potential. Looking at the numbers, Host Hotels & Resorts ended the most recent session at $17.11, and while the stock has dipped by 1.2% over the past week, it is holding steady for the past...
NYSE:ARIS
NYSE:ARISEnergy Services

Aris Water Solutions (ARIS): Assessing Valuation After a 45% One-Year Shareholder Return

Aris Water Solutions (ARIS) shares have climbed over the past year, returning 45% to investors. The company’s revenue and net income have both improved, and there are clear signals of ongoing business expansion. See our latest analysis for Aris Water Solutions. Momentum for Aris Water Solutions has been steady, with a 1-year total shareholder return of 45% that reflects sustained growth and renewed investor confidence. Recent results suggest that the company’s improving fundamentals are...
NasdaqGS:ANGO
NasdaqGS:ANGOMedical Equipment

Why AngioDynamics (ANGO) Is Up 10.9% After Raising Sales Guidance and Narrowing Quarterly Loss

On October 2, 2025, AngioDynamics, Inc. reported first quarter earnings, announcing sales of US$75.71 million versus US$67.49 million a year earlier and a reduced net loss of US$10.9 million compared to US$12.8 million in the previous year, alongside basic and diluted loss per share of US$0.26. The company also raised its full fiscal year 2026 sales guidance, now expecting net sales of US$308 million to US$313 million, reflecting a more optimistic outlook on financial and operational...
NasdaqGS:CAI
NasdaqGS:CAIBiotechs

How Does Caris Life Sciences Stack Up After Recent 18.7% Drop?

Trying to decide what to do with Caris Life Sciences stock? You are not alone. With biotech on investors’ minds and volatility ever-present, a confident approach matters more than ever. Over the past month, Caris Life Sciences shares have slipped 18.7%, but that drawdown follows a period of growth, leaving the stock up 6.1% year-to-date. A smaller dip of just 0.1% over the last week hints that the market may be stabilizing after recent headwinds, possibly as investors process shifts in the...
NasdaqCM:RITR
NasdaqCM:RITRReal Estate

Reitar Logtech Holdings (NasdaqCM:RITR): Evaluating Valuation Following Strategic Qatar Logistics Partnership

Reitar Logtech Holdings (NasdaqCM:RITR) has made headlines with its newly signed strategic cooperation and investment agreement with NEXX, launching a Smart Fulfillment Center project in Qatar. This move marks Reitar’s entry into the rapidly evolving Middle Eastern logistics sector. See our latest analysis for Reitar Logtech Holdings. Reitar Logtech’s leap into Qatar’s logistics scene comes at a time when its total shareholder return over the past year has dipped slightly by 0.4%. While the...